# Evaluation of Virtual Reality to Save Morphinic in the Treatment of Vaso-occlusive Seizures of Sickle Cell Patients Consulting in the Emergency Room

> **NCT04756375** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 97 (actual)

## Conditions studied

- Vaso-occlusive Crisis
- Sickle Cell Disease

## Interventions

- **DEVICE:** Virtual Reality
- **OTHER:** Usual Care

## Key facts

- **NCT ID:** NCT04756375
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-04
- **Primary completion:** 2021-09-02
- **Final completion:** 2021-09-02
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2021-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04756375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04756375, "Evaluation of Virtual Reality to Save Morphinic in the Treatment of Vaso-occlusive Seizures of Sickle Cell Patients Consulting in the Emergency Room". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04756375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*